Compounds of Formula (1) and their pharmaceutically acceptable salts are described: Formula (1) Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
[EN] PYRROL DERIVATIVES WITH ANTIBACTERIAL ACTIVITY<br/>[FR] DERIVES DE PYRROL A ACTIVITE ANTIBACTERIENNE
申请人:ASTRAZENECA AB
公开号:WO2005026149A1
公开(公告)日:2005-03-24
Compounds of Formula (1) and their pharmaceutically acceptable salts are described: Formula (1) Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
[EN] SUBSTITUTED 6- (PYRIMIDIN-4-YL) QUINOLINE COMPOUNDS AS CYCLIN DEPENDENT KINASE INHIBITORS<br/>[FR] COMPOSÉS 6-(PYRIMIDIN-4-YL) QUINOLÉIQUES SUBSTITUÉS UTILISÉS COMME INHIBITEURS DE KINASE DÉPENDANTE DES CYCLINES
申请人:[en]BEIGENE , LTD.
公开号:WO2023208173A1
公开(公告)日:2023-11-02
This disclosure provides compounds containing 6- (pyrimidin-4-yl) quinoline structure, the use thereof for selectively inhibiting the activity of CDK4, and pharmaceutical compositions comprising the compounds as treatment of various diseases including cancer.